Grace Lai-Hung Wong

Grace Lai-Hung Wong

UNVERIFIED PROFILE

Are you Grace Lai-Hung Wong?   Register this Author

Register author
Grace Lai-Hung Wong

Grace Lai-Hung Wong

Publications by authors named "Grace Lai-Hung Wong"

Are you Grace Lai-Hung Wong?   Register this Author

100Publications

2190Reads

32Profile Views

Reply to Sun et al.

Clin Infect Dis 2020 Jun;70(12):2748-2749

Department of Medicine and Therapeutics, Chinese University of Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz725DOI Listing
June 2020

Reply.

Gastroenterology 2020 Jun 1;158(8):2312-2313. Epub 2020 Apr 1.

Medical Data Analytic Centre and, Department of Medicine and Therapeutics and, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2020.03.052DOI Listing
June 2020

Modelling the Economic and Clinical Burden of Non-Alcoholic Steatohepatitis in East Asia: Data from Hong Kong.

Hepatol Res 2020 Jun 14. Epub 2020 Jun 14.

Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13535DOI Listing
June 2020

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.

Lancet Gastroenterol Hepatol 2020 Jun 22. Epub 2020 Jun 22.

Department of Medicine and Therapeutics, and Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(20)30190-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308747PMC
June 2020

Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.

J Hepatol 2020 May 16;72(5):847-854. Epub 2019 Dec 16.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.12.005DOI Listing
May 2020

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis.

Clin Gastroenterol Hepatol 2020 May 7. Epub 2020 May 7.

Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Nedlands, Australia; Department of Hepatology, Sir Charles Gairdner Hospital, Nedlands Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2020.04.083DOI Listing
May 2020

Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".

J Hepatol 2020 May 15. Epub 2020 May 15.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2020.04.029DOI Listing
May 2020

Application of transient elastography in nonalcoholic fatty liver disease.

Clin Mol Hepatol 2020 Apr 8;26(2):128-141. Epub 2019 Nov 8.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2019.0001nDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160347PMC
April 2020

Use of hepatitis B virus core-related antigen to evaluate natural history of chronic hepatitis B.

J Gastroenterol Hepatol 2020 Apr 15. Epub 2020 Apr 15.

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.15058DOI Listing
April 2020

Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective.

Best Pract Res Clin Obstet Gynaecol 2020 Apr 7. Epub 2020 Apr 7.

New York University, New York City, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpobgyn.2020.03.014DOI Listing
April 2020

Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma.

Liver Cancer 2020 Apr 21;9(2):167-181. Epub 2019 Nov 21.

Department of Anatomical and Cellular Pathology, Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000504252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206612PMC
April 2020

Reply.

Hepatology 2020 Mar 5;71(3):1134. Epub 2020 Mar 5.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.31005DOI Listing
March 2020

How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region?

Lancet Gastroenterol Hepatol 2020 Feb 15;5(2):103-105. Epub 2019 Dec 15.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30338-3DOI Listing
February 2020

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B.

J Gastroenterol Hepatol 2020 Feb 7. Epub 2020 Feb 7.

Faculty of Medicine, Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.15007DOI Listing
February 2020

Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.

J Hepatol 2020 Jan 6;72(1):57-66. Epub 2019 Sep 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.08.023DOI Listing
January 2020

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.

Gastroenterology 2020 01 28;158(1):215-225.e6. Epub 2019 Sep 28.

Institute of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong; Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.09.025DOI Listing
January 2020

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Aliment Pharmacol Ther 2019 11 16;50(9):1037-1048. Epub 2019 Sep 16.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15499DOI Listing
November 2019

Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness.

Hepatology 2019 09 15;70(3):971-981. Epub 2019 Mar 15.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30522
Publisher Site
http://dx.doi.org/10.1002/hep.30522DOI Listing
September 2019

Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other?

J Hepatol 2019 09 14;71(3):453-455. Epub 2019 Jun 14.

CRC "A. M. and A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.05.017DOI Listing
September 2019

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease.

Clin Gastroenterol Hepatol 2019 Sep 28. Epub 2019 Sep 28.

Centre d'Investigation de la Fibrose Hépatique, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.09.027DOI Listing
September 2019

Non-alcoholic fatty liver disease in Asia: How is it different from the West?

J Gastroenterol Hepatol 2019 08;34(8):1267-1268

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14813DOI Listing
August 2019

Unmet need in chronic hepatitis B management.

Clin Mol Hepatol 2019 06 12;25(2):172-180. Epub 2019 Feb 12.

Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2018.0106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589853PMC
June 2019

Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.

Aliment Pharmacol Ther 2019 06 25;49(12):1509-1517. Epub 2019 Apr 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15269DOI Listing
June 2019

Current Knowledge of Occult Hepatitis B Infection and Clinical Implications.

Semin Liver Dis 2019 05 25;39(2):249-260. Epub 2019 Mar 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1678728
Publisher Site
http://dx.doi.org/10.1055/s-0039-1678728DOI Listing
May 2019

Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues".

J Hepatol 2019 04 8;70(4):796-797. Epub 2019 Jan 8.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.11.031DOI Listing
April 2019

Towards finite oral antiviral treatment for chronic hepatitis B.

Lancet Gastroenterol Hepatol 2019 04 20;4(4):260-262. Epub 2019 Feb 20.

Institute of Digestive Disease, Department of Medicine and Therapeutics, and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30045-7DOI Listing
April 2019

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.

J Hepatol 2019 03 25;70(3):361-370. Epub 2018 Oct 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.10.014DOI Listing
March 2019

Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].

J Hepatol 2019 Mar 8;70(3):581. Epub 2019 Jan 8.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.12.010DOI Listing
March 2019

Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.

Liver Int 2019 02 25;39(2):271-279. Epub 2018 Sep 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13953DOI Listing
February 2019

The emerging role of big data in gastroenterology and hepatology.

J Gastroenterol Hepatol 2019 Feb;34(2):307-308

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.14606
Publisher Site
http://dx.doi.org/10.1111/jgh.14606DOI Listing
February 2019

Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.

J Gastroenterol Hepatol 2019 Jan 27;34(1):241-248. Epub 2018 Jun 27.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14311DOI Listing
January 2019

Tips for Responding to Reviewers' Comments-from an Editor's or Reviewer's Points of View.

Gut Liver 2019 01;13(1):7-10

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5009/gnl18361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347010PMC
January 2019

Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

J Hepatol 2018 12 22;69(6):1349-1356. Epub 2018 Aug 22.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.08.011DOI Listing
December 2018

Letter: chronic kidney disease risk in patients with chronic hepatitis B-authors' reply.

Aliment Pharmacol Ther 2018 12;48(11-12):1324

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15031DOI Listing
December 2018

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment.

Aliment Pharmacol Ther 2018 11 20;48(9):984-992. Epub 2018 Aug 20.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14945DOI Listing
November 2018

On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.

Am J Gastroenterol 2018 11 12;113(11):1629-1638. Epub 2018 Oct 12.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41395-018-0247-9DOI Listing
November 2018

Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?

J Gastroenterol Hepatol 2018 Oct 7;33(10):1787-1794. Epub 2018 May 7.

Institute of Digestive Disease, The Chinese University of Hong Kong, Sha Tin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.14150
Publisher Site
http://dx.doi.org/10.1111/jgh.14150DOI Listing
October 2018

Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.

J Hepatol 2018 Oct;69(4):793-802

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.05.009DOI Listing
October 2018

Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.

Clin Infect Dis 2018 09;67(8):1278-1284

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy234DOI Listing
September 2018

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

J Hepatol 2018 08 16;69(2):278-285. Epub 2018 Mar 16.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.02.032DOI Listing
August 2018

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.

Nat Rev Gastroenterol Hepatol 2018 08;15(8):461-478

University of Buenos Aires, Institute of Medical Research A Lanari, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41575-018-0014-9
Publisher Site
http://dx.doi.org/10.1038/s41575-018-0014-9DOI Listing
August 2018

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend.

Clin Mol Hepatol 2018 06 22;24(2):108-113. Epub 2018 Jan 22.

Institute of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2017.0068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038942PMC
June 2018

Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.

Clin Gastroenterol Hepatol 2018 05 12;16(5):765-773.e2. Epub 2017 Dec 12.

Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565173145
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2017.12.009DOI Listing
May 2018

Non-invasive assessments for liver fibrosis: The crystal ball we long for.

J Gastroenterol Hepatol 2018 May 25;33(5):1009-1015. Epub 2018 Mar 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Sha Tin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14103DOI Listing
May 2018

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.

J Gastroenterol Hepatol 2018 Apr 26;33(4):934-941. Epub 2018 Jan 26.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14003DOI Listing
April 2018

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Am J Gastroenterol 2017 Dec 31;112(12):1812-1823. Epub 2017 Oct 31.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong,China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.389DOI Listing
December 2017

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

J Hepatol 2017 11 24;67(5):902-908. Epub 2017 Jun 24.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.019DOI Listing
November 2017

Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.09.020DOI Listing
October 2017

Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278173233
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2017.09.018DOI Listing
October 2017

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

J Hepatol 2017 09 12;67(3):577-584. Epub 2017 May 12.

Centre d'Investigation de la Fibrose Hépatique, Hôpital Haut-Lévêque, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.05.005DOI Listing
September 2017

Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance".

J Hepatol 2017 Sep 19. Epub 2017 Sep 19.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.08.026DOI Listing
September 2017

HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.

Am J Gastroenterol 2017 Jul 25;112(7):1111-1119. Epub 2017 Apr 25.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.123DOI Listing
July 2017

Reply.

Hepatology 2017 05 30;65(5):1780. Epub 2017 Mar 30.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29000DOI Listing
May 2017

Eliminating hepatitis B virus as a global health threat.

Lancet Infect Dis 2016 12 13;16(12):1313-1314. Epub 2016 Sep 13.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(16)30214-6DOI Listing
December 2016

Reply.

Hepatology 2016 11 17;64(5):1820-1821. Epub 2016 May 17.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28595DOI Listing
November 2016

Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.

Hepatology 2016 11 1;64(5):1507-1517. Epub 2016 Oct 1.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28778DOI Listing
November 2016

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.

Lancet Gastroenterol Hepatol 2016 09 10;1(1):56-67. Epub 2016 Aug 10.

Liver Research Group, Australian National University Medical School at The Canberra Hospital, Woden, ACT, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(16)30011-5DOI Listing
September 2016

Reply.

Hepatology 2016 08 18;64(2):685-6. Epub 2015 Dec 18.

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28305DOI Listing
August 2016

Virus and Host Testing to Manage Chronic Hepatitis B.

Clin Infect Dis 2016 06;62 Suppl 4:S298-305

Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889896PMC
June 2016

A LEAN treatment for non-alcoholic steatohepatitis.

Lancet 2016 Feb 20;387(10019):628-30. Epub 2015 Nov 20.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00982-4DOI Listing
February 2016

Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.

J Hepatol 2015 Nov 21;63(5):1190-7. Epub 2015 Jul 21.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.07.009DOI Listing
November 2015

Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.

Hepatology 2015 Sep 28;62(3):684-93. Epub 2015 Jul 28.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27894DOI Listing
September 2015

Personalized management of cirrhosis by non-invasive tests of liver fibrosis.

Clin Mol Hepatol 2015 Sep 30;21(3):200-11. Epub 2015 Sep 30.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. ; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2015.21.3.200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612280PMC
September 2015

Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet.

World J Hepatol 2015 Aug;7(18):2133-5

Grace Lai-Hung Wong, Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4254/wjh.v7.i18.2133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550867PMC
August 2015